INCYTE PHARMACEUTICALS INC
POS AM, 1999-09-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INSURED MUNICIPALS INC TR & INV QUAL TAX EX TR MULTI SER 162, 497J, 1999-09-29
Next: NUTRITION MANAGEMENT SERVICES CO/PA, NT 10-K, 1999-09-29



   As filed with the Securities and Exchange Commission on September 29, 1999
                                                      Registration No. 333-73125

================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 ---------------
                         POST-EFFECTIVE AMENDMENT NO. 1
                                       TO
                                    FORM S-3
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933
                                 ---------------

                          INCYTE PHARMACEUTICALS, INC.
             (Exact name of registrant as specified in its charter)

              Delaware                                94-3136539

     (State or other jurisdiction of       (I.R.S. Employer Identification No.)
      incorporation or organization)

                                3160 Porter Drive
                           Palo Alto, California 94304
                                 (650) 855-0555
              (Address, including zip code, and telephone number,
       including area code, of registrant's principal executive offices)

                                ROY A. WHITFIELD
                             Chief Executive Officer
                          INCYTE PHARMACEUTICALS, INC.
                                3160 Porter Drive
                           Palo Alto, California 94304
                                 (650) 855-0555
            (Name, address, including zip code, and telephone number,
                   including area code, of agent for service)

                                   Copies to:

                                 STANTON D. WONG
                                  BRIAN M. WONG
                          Pillsbury Madison & Sutro LLP
                                  P.O. Box 7880
                         San Francisco, California 94120

                                 ---------------

================================================================================

<PAGE>


                           TERMINATION OF REGISTRATION

     Incyte Pharmaceuticals, Inc. (the "Registrant") hereby removes and
withdraws from registration 207,071 shares of Common Stock, $.001 par value, of
the Registrant. The Shares were unsold at the termination of the offering
covered by this Registration Statement.

<PAGE>

                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Post-Effective
Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Palo Alto, State of California, on September 29, 1999.

                                           INCYTE PHARMACEUTICALS, INC.


                                           By        /s/ ROY A. WHITFIELD
                                             -----------------------------------
                                                       Roy A. Whitfield
                                            Chief Executive Officer and Director


     KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears
below constitutes and appoints Roy A. Whitfield, Randal W. Scott, and Elias
Bendekgey agents, each with full power of substitution and resubstitution, for
him or her and in his or her name, place and stead, in any and all capacities,
to sign any and all amendments, including post-effective amendments, to this
Registration Statement, and to file the same, with exhibits thereto and other
documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, and each of them, full power
and authority to do and perform each and every act and thing requisite and
necessary to be done, as fully to all intents and purposes as he or she might or
could do in person, hereby ratifying and confirming all that each of said
attorneys-in-fact and agents or their substitute or substitutes may lawfully do
or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Act, this Post-Effective
Amendment No. 1 to the Registration Statement has been signed below by the
following persons in the capacities and on the dates indicated.

<TABLE>

<CAPTION>

          Name                          Title                              Date
          ----                          -----                              ----
<S>                         <C>                                       <C>


/s/ ROY A. WHITFIELD
- ----------------------      Chief Executive Officer (Principal        September 29, 1999
   Roy A. Whitfield         Executive Officer) and Director


 /s/ ELIAS BENDEKGEY
- ----------------------      General Counsel and Interim Chief         September 21, 1999
    Elias Bendekgey         Financial Officer


  /s/ TIMOTHY HENN
- ----------------------      Controller (Principal Accounting          September 21, 1999
     Timothy Henn           Officer)

</TABLE>

<PAGE>

<TABLE>
<S>                                        <C>                         <C>



                 *
- -------------------------------            Chairman of the Board       February 26, 1999
       Jeffrey J. Collinson
                 *
- -------------------------------            Director                    February 26, 1999
          Barry M. Bloom
                 *
- -------------------------------            Director                    February 26, 1999
        Frederick B. Craves
                 *
- -------------------------------            Director                    February 26, 1999
            Jon S. Saxe
                 *
- -------------------------------            Director                    February 26, 1999
          Randal W. Scott



* By:   /s/ ROY A. WHITFIELD
     -----------------------------
             Roy A. Whitfield
             Attorney-in-Fact
</TABLE>




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission